Find Clinical Trials | Cedars-Sinai

165 results found

Lung

Incorporating Pathologic Complete Response in Non-Small Cell Lung Cancer to Optimize Immunotherapy

The purpose of this study is to compare the usual approach of observation (closely watching a patient’s condition after surgery) to taking an immunotherapy drug, durvalumab (MEDI4736), in people with early-stage, non-small cell lung cancer ...

Kidney

Short-Term Intensified Pembrolizumab and Tivozanib for High-Risk Renal Cell Carcinoma

The purpose of this study is to evaluate whether the addition of a drug called tivozanib to another drug, pembrolizumab, is better than the usual approach (pembrolizumab alone) for treating advanced kidney cancer. Specifically, researchers ...

Prostate

Ifinatamab Deruxtecan Versus Docetaxel in Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called ifinatamab deruxtecan (I-DXd) in treating people with metastatic castration-resistant prostate cancer (mCRPC), as compared to the standard-of-care treatment, ...

Gynecologic Cancer

Proactive Costs of Care Intervention Among Patients With Gynecologic Cancer on Active Therapy

This study focuses on patients diagnosed with gynecologic cancer who are currently receiving treatment at Cedars-Sinai. The purpose of the study is to evaluate the Proactive Costs of Care (PCOC) educational booklet and cost tracker; ...

Other

Proactive Costs of Care for Caregivers Study

Primary feasibility objective: 1. Evaluate percentage of intervention completion, defined as completion of the up to 30 minute Proactive Costs of Care (PCOC) intervention with the lay educator, among cancer caregivers. Secondary efficacy objectives: 2. ...